TGA
AMRX icon

TPG GP A’s Amneal Pharmaceuticals AMRX Stock Holding History

TPG GP A’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$153M Hold
12,328,767
– – 4.17% 6
2025
Q4 		$155M Hold
12,328,767
– – 5.78% 5
2025
Q3 		$123M Hold
12,328,767
– – 6.72% 4
2025
Q2 		$99.7M Hold
12,328,767
– – 5.32% 4
2025
Q1 		$103M Hold
12,328,767
– – 2.04% 11
2024
Q4 		$97.6M Hold
12,328,767
– – 1.58% 14
2024
Q3 		$103M Hold
12,328,767
– – 1.75% 14
2024
Q2 		$78.3M Hold
12,328,767
– – 1.22% 18
2024
Q1 		$74.7M Hold
12,328,767
– – 1.43% 22
2023
Q4 		$74.8M Hold
12,328,767
– – 1.21% 22
2023
Q3 		$52M Hold
12,328,767
– – 0.9% 24
2023
Q2 		$38.2M Hold
12,328,767
– – 0.56% 29
2023
Q1 		$17.1M Hold
12,328,767
– – 0.28% 33
2022
Q4 		$24.5M Sell
12,328,767
-3,884,600
-24% -$8.71M 0.48% 31
2022
Q3 		$32.8M Hold
16,213,367
– – 0.54% 29
2022
Q2 		$51.6M Hold
16,213,367
– – 0.8% 26
2022
Q1 		$67.6M Hold
16,213,367
– – 0.84% 27
2021
Q4 		$77.7M Buy
+16,213,367
New +$80.8M 0.78% 28

Other funds holding AMRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

TPG GP A's AMRX Position: Q1 2026 in Review

TPG GP A held its Amneal Pharmaceuticals (AMRX) position steady in Q1 2026 at 12,328,767 shares worth $153M. The position accounts for 4.17% of the portfolio, ranked #6.

TPG GP A first reported a position in AMRX in Q4 2021 and has held it in 18 quarters since. The position peaked at $155M in Q4 2025. 315 funds tracked by Wall St. Rank hold AMRX as of Q1 2026.

  • TPG GP A held 12,328,767 shares of Amneal Pharmaceuticals worth $153M as of Q1 2026.
  • TPG GP A left its Amneal Pharmaceuticals share count unchanged in Q1 2026.
  • Amneal Pharmaceuticals made up 4.17% of TPG GP A's portfolio in Q1 2026, its #6 holding.
  • TPG GP A first reported a position in Amneal Pharmaceuticals in Q4 2021 and has held it in 18 quarters since.
  • TPG GP A's Amneal Pharmaceuticals position peaked at $155M in Q4 2025.
  • 315 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q1 2026.

Based on TPG GP A's 13F filing for Q1 2026, filed 15 May 2026.